References
- Ford AC, Moayyedi P, Lacy BE, et al. American College of Gastroenterology monograph on the management of irritable bowel syndrome and chronic idiopathic constipation. Am J Gastroenterol 2014;109(1 Suppl):S2
- National ambulatory medical care survey: 2010 outpatient department summary tables. Centers for Disease Control and Prevention (CfDCa), 2010. http://www.cdc.gov/nchs/ahcd/web_tables.htm#2010
- Martin BC, Barghout V, Cerulli A. Direct medical costs of constipation in the United States. Manag Care Interface 2006;19:43-9
- Lembo A, Camilleri M. Chronic constipation. New Engl J Med 2003;349:1360-8
- Johanson JF, Kralstein J. Chronic constipation: a survey of the patient perspective. Aliment Pharmacol Therapeut 2007;25:599-608
- Rey E, Talley NJ. Irritable bowel syndrome: novel views on the epidemiology and potential risk factors. Digest Liver Dis 2009;41:772-80
- Cremonini F, Talley NJ. Irritable bowel syndrome: epidemiology, natural history, health-care seeking and emerging risk factors. Gastroenterol Clin North Am 2005;34:189-204
- Choung RS, Branda ME, Chitkara D, et al. Longitudinal direct medical costs associated with constipation in women. Aliment Pharmacol Therapeut 2011;33:251-60
- Nyrop KA, Palsson OS, Levy RL, et al. Costs of health care for irritable bowel syndrome, chronic constipation, functional diarrhoea and functional abdominal pain. Aliment Pharmacol There 2007;26:237-48
- Singh G, Lingala V, Wang H, et al. Use of health care resources and cost of care for adults with constipation. Clin Gastroenterol Hepatol 2007;5:1053-8
- Cai Q, Buono J, Spalding W, et al. Healthcare costs among patients with chronic constipation: a retrspective claims analysis in a commercially insured population. J Med Econ 2014;17:148-58
- Doshi JA, Cai Q, Buono JL, et al. Economic burden of irritable bowel syndrome with constipation: a retrospective analysis of health care costs in a commercially insured population. J Manag Care Pharm 2014;20:382-90
- Talley N, Weaver A, Zinsmeister A, et al. Onset and disappearance of gastrointestinal symptoms and functional gastrointestinal disorders. Am J Epidemiol 1992;136:165-77
- St Sauver JL, Grossardt BR, Yawn BP, et al. Use of a medical records linkage system to enumerate a dynamic population over time: the Rochester epidemiology project. Am J Epidemiol 2011;173:1059-68
- Rey E, Locke GR, 3rd, Jung HK, et al. Measurement of abdominal symptoms by validated questionnaire: a 3-month recall timeframe as recommended by Rome III is not superior to a 1-year recall timeframe. Aliment Pharmacol Therapeut 2010;31:1237-47
- Rey E, Locke GR, 3rd, Jung HK, et al. Measurement of abdominal symptoms by validated questionnaire: a 3-month recall timeframe as recommended by Rome III is not superior to a 1-year recall timeframe. Alimentary Pharmacology & Therapeutics. 2010;31:1237-1247
- St Sauver JL, Grossardt BR, Leibson CL, et al. Generalizability of epidemiological findings and public health decisions: an illustration from the Rochester Epidemiology Project. Mayo Clin Proc 2012;87:151-60
- Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987;40:373-83
- Choung RS, Locke GR, 3rd, Rey E, et al. Factors associated with persistent and nonpersistent chronic constipation, over 20 years. Clin Gastroenterol Hepatol 2012;10:494-500
- Duan N, Manning WG, Morris CN, et al. A comparison of alternative models for the demand for medical care. J Bus Econ Stat 1983;1:115-26
- Sedgwick P. P values of confidence intervals. BMJ 2013;20:346-7
- Choung RS, Locke GR, Schleck CD, et al. A low response rate does not necessarily indicate non-response bias in gastroenterology survey research: A population-based study. Journal of Public Health (Germany) 2013;21:87-95